Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New ultrasound model may guide thyroid cancer surgery without extra scans

NCT ID NCT07357571

First seen Feb 01, 2026 · Last updated Jun 22, 2026 · Updated 16 times

Summary

This study looks at whether a special type of ultrasound (contrast-enhanced ultrasound) can predict how much cancer has spread to lymph nodes in patients with early-stage thyroid cancer. Researchers will review past images from 600 patients and compare them to surgical results. If the model works, it could help doctors decide the best treatment—like a less extensive surgery—without needing more invasive tests.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CONTRAST-ENHANCED ULTRASOUND are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • No. 33 Yingfeng Road, Haizhu District, Guangzhou City, Guangdong Province, Sun Yat-sen Memorial Hospital

    RECRUITING

    Guangzhou, Guangzhou, 510288, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Sun Yat-sen Memorial Hospital

    RECRUITING

    Guangdong, Guangzhou, 510000, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact Phone: •••-•••-•••• Email: •••••@•••••

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

contrast-enhanced ultrasound

What this could lead to

If successful, this could provide a non-invasive way to predict lymph node metastasis burden, helping doctors choose the right surgery for thyroid cancer patients.

What could go wrong

This is a retrospective study, not a controlled trial, so results may not be definitive. The model's accuracy depends on image quality and expert analysis, which may vary across centers.

Conditions

The condition(s) this trial relates to.

Thyroid Cancer, Papillary thyroid gland papillary carcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.